Report overview
This report aims to provide a comprehensive presentation of the global market for B Cell Maturation Antigen Targeted Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding B Cell Maturation Antigen Targeted Therapy. This report contains market size and forecasts of B Cell Maturation Antigen Targeted Therapy in global, including the following market information:
Global B Cell Maturation Antigen Targeted Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global B Cell Maturation Antigen Targeted Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Antibody-Drug Conjugates Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of B Cell Maturation Antigen Targeted Therapy include GlaxoSmithKline, Johnson & Johnson, Amgen, Seagen, AbbVie, Novartis, BioTherapeutics, Celgene and Bluebird Bio, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the B Cell Maturation Antigen Targeted Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global B Cell Maturation Antigen Targeted Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global B Cell Maturation Antigen Targeted Therapy Market Segment Percentages, by Type, 2022 (%)
Antibody-Drug Conjugates
CAR-T Cells and Bispecific T Cell Engagers
Global B Cell Maturation Antigen Targeted Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global B Cell Maturation Antigen Targeted Therapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global B Cell Maturation Antigen Targeted Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global B Cell Maturation Antigen Targeted Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies B Cell Maturation Antigen Targeted Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies B Cell Maturation Antigen Targeted Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Johnson & Johnson
Amgen
Seagen
AbbVie
Novartis
BioTherapeutics
Celgene
Bluebird Bio
Bristol Mayer Squibb
Carsgen Therapeutics
Juno Therapeutics
Cogent Bioscience
CRISPR Therapeutics
Allogene Therapeutics
Harpoon Therapeutics
Poseida Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of B Cell Maturation Antigen Targeted Therapy, market overview.
Chapter 2: Global B Cell Maturation Antigen Targeted Therapy market size in revenue.
Chapter 3: Detailed analysis of B Cell Maturation Antigen Targeted Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of B Cell Maturation Antigen Targeted Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
